We address both the cause and the consequence of Type 1 Diabetes in a combined therapy pairing β-cell replacement with protection from autoimmune attack.
Synthetic Insulin Project (Induction of mesenchymal stem cells into insulin secreting cells as diabetes therapy)
Oana Gavriliuc - Postdoc, Project leader , Prof. Dr. Virgil Paunescu - Mentor, Head of laboratory
What is diabetes?
Diabetes is a serious life-long condition that afflicts more than 380 million people worldwide.
Researchers at Harvard Stem Cell Institute have announced that they have made a giant leap towards a truly effective treatment for diabetes when they have obtained, for the first time, in the massive...Read more
The Center of Immunology and Transplant, a research nucleus within the Hospital, is oriented towards cellular therapies, regenerative medicine and immunological aspects of gene and cell therapies.
An academic institution, providing higher education in the medical field, also actively pursuing biomedical research activities financed by several national and international grants.